Entera Bio ENTX
NASDAQ ENTX
$3.22 -0.02 (-0.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entera Bio (ENTX) Non-Current Deferred Tax Liability (2021 - 2024)

Updated

Analysis

Entera Bio (ENTX) Non-Current Deferred Tax Liability (2021 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Entera Bio 563.51 Mn 269.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 14,000.00
Jun 30, 2024 14,000.00
Mar 31, 2024 14,000.00
Dec 31, 2023 14,000.00
Sep 30, 2023 15,000.00
Jun 30, 2023 43,000.00
Mar 31, 2023 43,000.00
Dec 31, 2022 43,000.00
Sep 30, 2022 66,000.00
Jun 30, 2022 280,000.00
Mar 31, 2022 250,000.00
Dec 31, 2021 217,000.00
API Access

Entera Bio Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ENTX&period=max&api_key=YOUR_API_KEY